Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Over the last 12 months, insiders at Sana Biotechnology, Inc. have bought $18M and sold $3.32M worth of Sana Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at Sana Biotechnology, Inc. have bought $6.23M and sold $3.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: NELSEN ROBERT () — $42M. CRANDELL KEITH (10 percent owner) — $30M. ARCH Venture Fund X, L.P. (10 percent owner) — $6M.
The last purchase of 1,090,909 shares for transaction amount of $6M was made by NELSEN ROBERT () on 2024‑02‑08.
2025-01-08 | Sale | See Remark 1 | 290,912 0.1729% | $6.49 | $1.89M | -44.12% | ||
2024-09-25 | Sale | director | 150,000 0.0641% | $3.89 | $583,170 | +9.83% | ||
2024-09-24 | Sale | director | 150,000 0.0673% | $4.08 | $612,570 | +4.56% | ||
2024-03-08 | Sale | director | 25,000 0.0113% | $9.45 | $236,300 | -41.99% | ||
2024-02-08 | 1.09M 0.5382% | $5.50 | $6M | -4.38% | ||||
2024-02-08 | 10 percent owner | 1.09M 0.5382% | $5.50 | $6M | -4.38% | |||
2024-02-08 | 10 percent owner | 1.09M 0.5382% | $5.50 | $6M | -4.38% | |||
2023-12-15 | Sale | EVP, Chief Business Officer | 75,000 0.0378% | $4.00 | $300,098 | +46.07% | ||
2023-06-07 | Sale | 10 percent owner | 200,000 0.1051% | $6.24 | $1.25M | -6.12% | ||
2023-06-06 | Sale | 10 percent owner | 203,758 0.106% | $6.31 | $1.28M | -8.04% | ||
2023-05-26 | Sale | 10 percent owner | 82,000 0.0425% | $6.23 | $510,573 | -7.64% | ||
2023-05-25 | Sale | 10 percent owner | 115,372 0.0614% | $6.35 | $732,866 | -6.89% | ||
2023-05-24 | Sale | 10 percent owner | 347,870 0.1843% | $6.57 | $2.28M | -10.19% | ||
2022-03-21 | 28,000 0.016% | $7.30 | $204,400 | -19.10% | ||||
2022-02-18 | Sale | EVP & General Counsel | 333 0.0002% | $6.28 | $2,091 | -5.54% | ||
2021-09-16 | Sale | EVP, Head of Development & CMO | 1,627 0.0009% | $26.00 | $42,302 | -69.16% | ||
2021-09-15 | Sale | EVP, Head of Development & CMO | 58,373 0.0323% | $26.07 | $1.52M | -69.32% | ||
2021-09-10 | Sale | EVP, Chief Business Officer | 1,477 0.0008% | $25.00 | $36,925 | -67.78% | ||
2021-09-09 | Sale | EVP, Chief Business Officer | 64,671 0.0361% | $25.01 | $1.62M | -67.46% | ||
2021-09-03 | Sale | EVP, Chief Business Officer | 700 0.0004% | $25.00 | $17,500 | -67.18% |
CRANDELL KEITH | 10 percent owner | 12446022 5.5745% | $3.26 | 1 | 0 | |
NELSEN ROBERT | 12446022 5.5745% | $3.26 | 1 | 0 | ||
ARCH Venture Fund X, L.P. | 10 percent owner | 12446022 5.5745% | $3.26 | 1 | 0 | |
FMR LLC | See Remark 1 | 4541511 2.0341% | $3.26 | 0 | 1 | |
Mulligan Richard | director | 2698121 1.2085% | $3.26 | 0 | 2 | |
Yang Patrick Y | director | 149250 0.0668% | $3.26 | 1 | 1 | <0.0001% |
AGARWAL SUNIL | EVP, Head of Development & CMO | 1550000 0.6942% | $3.26 | 0 | 2 | |
Flagship Ventures Fund V General Partner LLC | 10 percent owner | 1380277 0.6182% | $3.26 | 0 | 5 | |
Hordo Christian | EVP, Chief Business Officer | 867455 0.3885% | $3.26 | 0 | 7 | |
MacDonald James J. | EVP & General Counsel | 429417 0.1923% | $3.26 | 0 | 1 | |
Bilenker Joshua H. | director | 20000 0.009% | $3.26 | 1 | 0 |
Flagship Pioneering | $250.02M | 11.29 | 25M | New | +$250.02M | 16.4 | |
Fidelity Investments | $220.43M | 9.95 | 22.04M | New | +$220.43M | 0.02 | |
The Vanguard Group | $121.55M | 5.49 | 12.16M | +24.07% | +$23.58M | <0.01 | |
Baillie Gifford Co | $106.56M | 4.81 | 10.66M | New | +$106.56M | 0.08 | |
Canada Pension Plan Investment Board | $101.75M | 4.59 | 10.18M | 0% | +$0 | 0.1 | |
Capital World Investors | $54.49M | 2.46 | 5.45M | New | +$54.49M | 0.01 | |
T Rowe Price Investment Management Inc | $48.02M | 2.17 | 4.8M | New | +$48.02M | 0.03 | |
Crestline Management Lp | $33.66M | 1.52 | 3.37M | 0% | +$0 | 3.19 | |
Alphabet | $28.13M | 1.27 | 2.81M | New | +$28.13M | 0.23 | |
Baker Bros Advisors LP | $23.81M | 1.08 | 2.38M | +19.05% | +$3.81M | 0.17 | |
Citadel Advisors LLC | $18.87M | 0.85 | 1.89M | +4,632.56% | +$18.47M | 0.01 | |
Morgan Stanley | $14.9M | 0.67 | 1.49M | New | +$14.9M | <0.01 | |
JPMorgan Chase | $11.05M | 0.5 | 1.11M | New | +$11.05M | <0.01 | |
Goldman Sachs | $8.53M | 0.39 | 852,776 | New | +$8.53M | <0.01 | |
Charles Schwab | $8.24M | 0.37 | 823,510 | +9.97% | +$746,750.00 | <0.01 | |
PFM Health Sciences | $6.75M | 0.31 | 675,000 | New | +$6.75M | 0.19 | |
SEB | $5.83M | 0.26 | 583,489 | New | +$5.83M | 0.03 | |
Bank of America | $5.48M | 0.25 | 548,027 | New | +$5.48M | <0.01 | |
Dimensional Fund Advisors | $5.25M | 0.24 | 525,007 | New | +$5.25M | <0.01 | |
Td Asset Management Inc | $5.21M | 0.24 | 521,112 | +43.7% | +$1.58M | 0.01 | |
Rafferty Asset Management Llc | $4.96M | 0.22 | 495,932 | New | +$4.96M | 0.01 | |
Citigroup | $4.7M | 0.21 | 469,670 | New | +$4.7M | <0.01 | |
Capital International Investors | $4.32M | 0.2 | 432,071 | New | +$4.32M | <0.01 | |
Ci Private Wealth Llc | $3.37M | 0.15 | 337,463 | -18.36% | -$758,970.00 | <0.01 | |
Massachusetts Financial Services Co Ma | $2.39M | 0.11 | 238,831 | -77.33% | -$8.14M | <0.01 | |
Renaissance Technologies | $1.73M | 0.08 | 172,900 | -41.41% | -$1.22M | <0.01 | |
RhumbLine Advisers | $1.57M | 0.07 | 156,847 | +3.2% | +$48,630.00 | <0.01 | |
Regents Of The University Of California | $1.56M | 0.07 | 156,254 | 0% | +$0 | 0.45 | |
AQR Capital | $1.56M | 0.07 | 155,792 | +540.67% | +$1.31M | <0.01 | |
Jane Street Capital | $1.46M | 0.07 | 146,456 | +613.93% | +$1.26M | <0.01 | |
AllianceBernstein | $1.25M | 0.06 | 125,325 | -1% | -$12,700.00 | <0.0001 | |
DekaBank | $1.12M | 0.05 | 112,300 | 0% | +$0 | <0.01 | |
Teachers Retirement System Of The State Of Kentucky | $1.04M | 0.05 | 104,442 | New | +$1.04M | 0.01 | |
Options Solutions Llc | $962,210.00 | 0.04 | 96,221 | New | +$962,210.00 | 0.55 | |
Profund Advisors Llc | $772,020.00 | 0.04 | 77,202 | New | +$772,020.00 | 0.02 | |
Los Angeles Capital Management LLC | $702,450.00 | 0.03 | 70,245 | -47.83% | -$643,930.00 | <0.01 | |
Susquehanna International Group | $593,970.00 | 0.03 | 59,397 | New | +$593,970.00 | <0.01 | |
Qube Research & Technologies | $554,150.00 | 0.03 | 55,415 | New | +$554,150.00 | <0.01 | |
Campbell Co Investment Adviser Llc | $524,590.00 | 0.02 | 52,459 | New | +$524,590.00 | 0.04 | |
Martingale Asset Management L P | $491,960.00 | 0.02 | 49,196 | -17.6% | -$105,070.00 | 0.01 | |
Clarius Group Llc | $468,250.00 | 0.02 | 46,825 | New | +$468,250.00 | 0.04 | |
Franklin Templeton Investments | $414,690.00 | 0.02 | 41,469 | +0.09% | +$370.00 | <0.0001 | |
China Universal Asset Management Co., Ltd. | $424,000.00 | 0.02 | 42,400 | +85.97% | +$196,000.00 | 0.04 | |
Jump Financial Llc | $394,000.00 | 0.02 | 39,400 | New | +$394,000.00 | <0.01 | |
ProShares | $326,900.00 | 0.02 | 32,690 | New | +$326,900.00 | <0.01 | |
Squarepoint Ops LLC | $302,240.00 | 0.01 | 30,224 | New | +$302,240.00 | <0.01 | |
Voya Investment Management LLC | $319,210.00 | 0.01 | 31,921 | New | +$319,210.00 | <0.0001 | |
Janus Henderson | $301,325.00 | 0.01 | 30,177 | +0.03% | +$99.85 | <0.0001 | |
Arizona State Retirement System | $270,880.00 | 0.01 | 27,088 | New | +$270,880.00 | <0.01 | |
Zurich Cantonal Bank | $247,680.00 | 0.01 | 24,768 | New | +$247,680.00 | <0.01 |